DNA from fecal immunochemical test can replace stool for detection of colonic lesions using a microbiota-based model

Microbiome

Volumn 4, Issue , 2016, Pages

  Baxter, Nielson T ^a   Koumpouras, Charles C ^a   Rogers, Mary A M ^a   Ruffin, Mack T ^b   Schloss, Patrick D ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Random forest; Colorectal cancer; Fecal immunochemical test; Gut microbiome; Microbiota

Indexed keywords

BACTERIAL DNA; RNA 16S;

ACTINOBACTERIA; ADULT; AGED; COLON CANCER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FECES ANALYSIS; FECES MICROFLORA; GENE SEQUENCE; HELICOBACTER; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MICROBIAL COMMUNITY; NONHUMAN; PANTOEA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; SEQUENCE HOMOLOGY; BACTERIUM; BLOOD; BLOOD EXAMINATION; CLASSIFICATION; COLORECTAL NEOPLASMS; DNA SEQUENCE; EARLY CANCER DIAGNOSIS; GENETICS; ISOLATION AND PURIFICATION; MASS SCREENING; MICROFLORA; MIDDLE AGED; NUCLEOTIDE SEQUENCE; OCCULT BLOOD; PROCEDURES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BACTERIA; BASE SEQUENCE; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HEMATOLOGIC TESTS; HUMANS; IMMUNOCHEMISTRY; MASS SCREENING; MICROBIOTA; MIDDLE AGED; OCCULT BLOOD; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA;

EID: 84995801941     PISSN: None     EISSN: 20492618     Source Type: Journal    
DOI: 10.1186/s40168-016-0205-y     Document Type: Review

References (22)

1. Siegel R, DeSantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64:104-17.
2. Centers for Disease Control and Prevention. Vital signs: colorectal cancer screening test use-United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62:881.
3. Hsia J, Kemper E, Kiefe C, Zapka J, Sofaer S, Pettinger M, Bowen D, Limacher M, Lillington L, Mason E, et al. The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative. Prev Med. 2000;31:261-70.
4. Jones RM, Devers KJ, Kuzel AJ, Woolf SH. Patient-reported barriers to colorectal cancer screening: a mixed-methods analysis. Am J Prev Med. 2010;38:508-16.
5. Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, García FA, Gillman MW, Harper DM, Kemper AR, Krist AH, et al. Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA. 2016;315:2564-75.
6. Hundt S, Haug U, Brenner H. Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med. 2009;150:162-9.
7. Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, Ahlquist DA, Berger BM. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370:1287-97.
8. Zackular JP, Rogers MA, Ruffin MT, Schloss PD. The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev Res. 2014;7:1112-21.
9. Zeller G, Tap J, Voigt AY, Sunagawa S, Kultima JR, Costea PI, Amiot A, Böhm J, Brunetti F, Habermann N, et al. Potential of fecal microbiota for earlystage detection of colorectal cancer. Mol Syst Biol. 2014;10:766.
10. Yu J, Feng Q, Wong SH, Zhang D, Liang Q yi, Qin Y, Tang L, Zhao H, Stenvang J, Li Y, et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut. 2015;0: 1-9.
11. Baxter NT, Ruffin MT, Rogers MA, Schloss PD. Microbiota-based model improves the sensitivity for detecting colonic lesions. Genome Medicine. 2016;8:1-10.
12. Kozich JJ, Westcott SL, Baxter NT, Highlander SK, Schloss PD. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl Environ Microbiol. 2013;79:5112-20.
13. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol. 2009;75:7537-41.
14. Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007;73:5261-7.
15. Calle ML, Urrea V, Boulesteix A-L, Malats N. AUC-RF: a new strategy for genomic profiling with random forest. Hum Hered. 2011;72:121-32.
16. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837-45.
17. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, Müller M. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC bioinformatics. 2011;12:1.
18. Yue JC, Clayton MK. A similarity measure based on species proportions. Commun Stat Theory Methods. 2005;34:2123-31.
19. Warren RL, Freeman DJ, Pleasance S, Watson P, Moore RA, Cochrane K, Allen-Vercoe E, Holt RA. Co-occurrence of anaerobic bacteria in colorectal carcinomas. Microbiome. 2013;1:16.
20. Sinha R, Chen J, Amir A, Vogtmann E, Inman KS, Flores-Munguia R, Sampson JN, Knight R, Chia N, et al. Collecting fecal samples for microbiome analyses in epidemiology studies. Cancer Epidemiology Biomarkers & Prevention. 2015;25:407-416.
21. Salter SJ, Cox MJ, Turek EM, Calus ST, Cookson WO, Moffatt MF, Turner P, Parkhill J, Loman NJ, Walker AW. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol. 2014;12:87.
22. Walker AW, Martin JC, Scott P, Parkhill J, Flint HJ, Scott KP. 16S rRNA genebased profiling of the human infant gut microbiota is strongly influenced by sample processing and pCR primer choice. Microbiome. 2015;3:1.